Pharmafile Logo

Sterling Pharma Solutions launches following management buyout

September 20, 2016 – Pharmaceutical –

UK-based Sterling Pharma Solutions has formed as an independent contract
development and manufacturing organisation (CDMO) following a
management buyout (MBO) of the UK based Dudley site.

Formerly
operating as Shasun Pharma Solutions within Strides Shasun, the process
of divesting the business to the current management team was completed
in September 2016.

Following the MBO, the newly divested
business has been rebranded and launched as Sterling Pharma Solutions.
The CDMO will specialise in delivering API development and manufacturing
solutions to support global pharmaceutical companies across the entire
product lifecycle.

The management team will be led by Kevin Cook
as CEO. Kevin joined the Dudley site in 1993. He says: ‘We are
delighted to complete the MBO and excited about building a global API
services business with roots in the north east of England. Our offering
is compelling as we can take projects from proof of concept to
commercial scale manufacture all on one site. We also have the
capabilities to handle the most hazardous chemical processes safely.

‘We
have experienced significant growth in the US and Europe in recent
years and believe the extensive capabilities at our site, coupled with
our heritage in the API services sector, provide us with an excellent
foundation to become the leading partner and provider of API services to
the pharmaceutical industry.’

Sterling Pharma Solutionsí site
in Dudley, UK, has been in existence for 47 years and is the UKís
largest provider of API development and manufacturing services to the
pharmaceutical industry.

Sterling Pharma Solutions
enquiries@sterlingpsl.com
Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG, United Kingdom